|
|
||||||||||
Research Articles |
OBJECTIVE: To determine whether oral contraceptives (OCs) can be used safely in a continuous manner to prevent monthly withdrawal bleeding. DATA SOURCES: Search of MEDLINE (1966-2000), International Pharmaceutical Abstracts (1970-2000), and the Internet. DATA SYNTHESIS: Several prospective studies have assessed the efficacy of continuous cycle OCs in preventing monthly withdrawal bleeding. Monophasic OCs are useful for this purpose. In studies using traditional OC regimens as a control, patients receiving continuously administered OCs experienced more breakthrough bleeding and spotting. Continuous use of OCs decreased headache and other menstruation-associated symptoms. No long-term trials have assessed the impact of continuous use of OCs on risk of cancer, thromboembolic disease, or fertility, concems raised by opponents of the method. CONCLUSIONS: From the data available, continuous use of OCs is an effective method for delaying withdrawal bleeding. Long-term safety data are not available.
This article has been cited by other articles:
![]() |
F. H. Stewart, A. M. Kaunitz, K. D. LaGuardia, D. L. Karvois, A. C. Fisher, A. J. Friedman, and for the ORTHO EVRA Extended Regimen Study Group Extended Use of Transdermal Norelgestromin/Ethinyl Estradiol: A Randomized Trial Obstet. Gynecol., June 1, 2005; 105(6): 1389 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Miller and J. P. Hughes Continuous Combination Oral Contraceptive Pills to Eliminate Withdrawal Bleeding: A Randomized Trial Obstet. Gynecol., April 1, 2003; 101(4): 653 - 661. [Abstract] [Full Text] [PDF] |
||||